S&H partners with Proscape Technologies

Share this article:

Avenue-e Health Strategies, the e-marketing division of Sudler & Hennessey, has formed a partnership with Proscape Technologies, the leading provider of interactive selling platforms.
Proscape is an established expert in a new breed of technology-based solutions, Marketing and Sales Effectiveness (MSE), which bridges marketing and sales to heighten selling effectiveness.
Now as an "authorized business partner" of Proscape, Avenue-e Health Strategies can deliver more effective digital detailing solutions for the Tablet PC, such as strategic setup, success criteria, implementation and rollout, and testing methodologies. By being authorized to develop and manage content for the Proscape system, Avenue-e can provide solutions that empower sales forces and make selling simpler.
"S&H and its e-marketing group, Avenue-e, are known as experts in developing professional promotion and interactive programs for top pharmaceutical companies," stated Anthony Manson, senior vice president and managing director of Avenue-e. "As with any new medium or device, it might look cool, but can the content attract and engage a healthcare physician?  Realizing the full potential of this new technology involves more than simply scanning a paper document and putting it on a PC tablet. It's about finding the right strategy and combining it with  multi-media tools to tell a powerful story--that ultimately makes the rep's job easier. The partnership of Avenue-e and Proscape Technologies, two cutting-edge companies, makes this all possible."

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.